Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
afforded, allergic, anemia, attack, Borough, collateral, concept, Condensed, conflict, County, CR, Craniofacial, cytokine, Dental, Dov, Elefant, gg, hardware, highest, HQ, ibrutinib, IDMC, immaterial, implicit, increasedand, Jared, keratopathy, land, lessor, leukopenia, lymphopenia, macroglobulinemia, mantle, MCL, military, MZL, nadir, neurological, neuropathy, neutropenia, NHL, OD, ODD, ORRsand, owner, pattern, peripheral, precipitated, presence, profound, promulgated, quad, raw, recovery, redeemed, relief, rental, respectfully, retrospective, rituximab, Roth, ROU, SeeNote, similarto, startup, subtype, syndrome, TBD, theCompany, thedollar, Thefollowing, thereunder, thrombocytopenia, timeline, turmoil, Union, unregistered, upset, variable
Filing tables
Filing exhibits
Related press release
CLRB similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Forms S-1 (File Nos. 333-221468, 333-214310, 333-214198, 333-208638, 333-225675, and 333-231888), Form S-3 (File No. 333-218514) and Forms S-8 (File Nos. 333-221469, 333-195255, 333-164398, 333-233460) of Cellectar Biosciences, Inc. and Subsidiary of our report dated March 6, 2020, relating to the consolidated financial statements, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern and appears in this annual report on Form 10-K for the years ended December 31, 2019 and 2018.
/s/ BAKER TILLY VIRCHOW KRAUSE, LLP | |
Madison, Wisconsin | |
March 9, 2020 |
1